Institution
Bombay Hospital, Indore
About: Bombay Hospital, Indore is a based out in . It is known for research contribution in the topics: Population & Medicine. The organization has 947 authors who have published 1201 publications receiving 19150 citations.
Topics: Population, Medicine, Health care, Tuberculosis, Liver disease
Papers published on a yearly basis
Papers
More filters
Chang Gung University1, National Taiwan University2, Prince of Songkla University3, The Chinese University of Hong Kong4, Auckland City Hospital5, National University of Singapore6, Yonsei University7, Bombay Hospital, Indore8, University of Queensland9, Aga Khan University10, University of Malaya11, Southern Medical University12, Kaohsiung Medical University13, University of Indonesia14, University of Santo Tomas15, University of Ulsan16, University of Tokyo17
TL;DR: New HBV management guidelines include general management, indications for fibrosis assessment, time to start or stop drug therapy, choice of drug to initiate therapy, when and how to monitor the patients during and after stopping drug therapy.
Abstract: Large volume of new data on the natural history and treatment of chronic hepatitis B virus (HBV) infection have become available since 2008. These include further studies in asymptomatic subjects with chronic HBV infection and community-based cohorts, the role of HBV genotype/naturally occurring HBV mutations, the application of non-invasive assessment of hepatic fibrosis and quantitation of HBV surface antigen and new drug or new strategies towards more effective therapy. To update HBV management guidelines, relevant new data were reviewed and assessed by experts from the region, and the significance of the reported findings was discussed and debated. The earlier "Asian-Pacific consensus statement on the management of chronic hepatitis B" was revised accordingly. The key terms used in the statement were also defined. The new guidelines include general management, indications for fibrosis assessment, time to start or stop drug therapy, choice of drug to initiate therapy, when and how to monitor the patients during and after stopping drug therapy. Recommendations on the therapy of patients in special circumstances, including women in childbearing age, patients with antiviral drug resistance, concurrent viral infection, hepatic decompensation, patients receiving immune suppression or chemotherapy and patients in the setting of liver transplantation and hepatocellular carcinoma, are also included.
1,016 citations
University of Texas MD Anderson Cancer Center1, University of California, San Francisco2, University of Bologna3, Bombay Hospital, Indore4, Hospital General de México5, Catholic University of Korea6, University of Rostock7, Medical University of Łódź8, University Medical Center Groningen9, Bristol-Myers Squibb10
TL;DR: Primary data showed superior efficacy for dasatinib compared with imatinib after 12 months, including significantly higher rates of complete cytogenetic response (CCyR), confirmed CCyR (primary end point), and major molecular response (MMR).
546 citations
University of Toronto1, Hannover Medical School2, Geneva College3, Pontifical Bolivarian University4, Alfred Hospital5, Peking Union Medical College6, Catholic University of the Sacred Heart7, University of Genoa8, King Abdulaziz University9, Bombay Hospital, Indore10, University of Ulsan11, Medisch Centrum Leeuwarden12, University of Copenhagen13, University of Texas Health Science Center at San Antonio14
TL;DR: Patient characteristics and ventilation practices have changed over time, and outcomes of mechanically ventilated patients have improved, and crude mortality in the intensive care unit decreased in 2010 compared with 1998.
Abstract: Rationale: Baseline characteristics and management have changed over time in patients requiring mechanical ventilation; however, the impact of these changes on patient outcomes is unclear.Objectives: To estimate whether mortality in mechanically ventilated patients has changed over time.Methods: Prospective cohort studies conducted in 1998, 2004, and 2010, including patients receiving mechanical ventilation for more than 12 hours in a 1-month period, from 927 units in 40 countries. To examine effects over time on mortality in intensive care units, we performed generalized estimating equation models.Measurements and Main Results: We included 18,302 patients. The reasons for initiating mechanical ventilation varied significantly among cohorts. Ventilatory management changed over time (P < 0.001), with increased use of noninvasive positive-pressure ventilation (5% in 1998 to 14% in 2010), a decrease in tidal volume (mean 8.8 ml/kg actual body weight [SD = 2.1] in 1998 to 6.9 ml/kg [SD = 1.9] in 2010), and an...
537 citations
Monash University1, King Abdulaziz Medical City2, King Saud University3, Alexandria University4, Bombay Hospital, Indore5, National Taiwan University6, China Medical University (PRC)7, Cairo University8, Yonsei University9, University of Tokyo10, Royal Prince Alfred Hospital11, Ain Shams University12, Memorial Hospital of South Bend13, Prince of Songkla University14, American University of Beirut15, University of Ulsan16, University of Geneva17
TL;DR: The hepatitis C pandemic has been systematically studied and characterized in North America and Europe, but this important public health problem has not received equivalent attention in other regions.
Abstract: Background: The hepatitis C pandemic has been systematically studied and characterized in North America and Europe, but this important public health problem has not received equivalent attention in other regions. Aim: The objective of this systematic review was to characterize hepatitis C virus (HCV) epidemiology in selected countries of Asia, Australia and Egypt, i.e. in a geographical area inhabited by over 40% of the global population. Methodology: Data references were identified through indexed journals and non-indexed sources. In this work, 7770 articles were reviewed and 690 were selected based on their relevance. Results: We estimated that 49.3‐64.0 million adults in Asia, Australia and Egypt are anti-HCV positive. China alone has more HCV infections than all of Europe or the Americas. While most countries had prevalence rates from 1 to 2% we documented several with relatively high prevalence rates, including Egypt (15%), Pakistan (4.7%) and Taiwan (4.4%). Nosocomial infection, blood transfusion (before screening) and injection drug use were identified as common risk factors in the region. Genotype 1 was common in Australia, China, Taiwan and other countries in North Asia, while genotype 6 was found in Vietnam and other Southeast Asian countries. In India and Pakistan genotype 3 was predominant, while genotype 4w as found in Middle Eastern countries such as Egypt, Saudi Arabia and Syria. Conclusion: We recommend implementation of surveillance systems to guide effective public health policy that may lead to the eventual curtailment of the spread of this pandemic infection.
515 citations
TL;DR: With this balloon dissector, the newly devised balloon breaks the septae, lifts the peritoneum atraumatically and creates a workable space in the retroperitoneum.
513 citations
Authors
Showing all 947 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Deepak Amarapurkar | 41 | 155 | 8960 |
| Bhim Singhal | 24 | 56 | 1620 |
| Nikhil Patel | 21 | 46 | 1810 |
| Amine Ali Zeggwagh | 21 | 47 | 2226 |
| Tushar J. Vachharajani | 20 | 144 | 1815 |
| Pravin Rathi | 17 | 146 | 1088 |
| Nadir E. Bharucha | 17 | 36 | 1430 |
| Satish V Khadilkar | 16 | 127 | 803 |
| Pravin Amin | 16 | 48 | 1251 |
| Shailesh V. Shrikhande | 15 | 23 | 999 |
| Pramil Tiwari | 14 | 53 | 858 |
| Pankaj Agarwal | 14 | 48 | 537 |
| Arjun A. Dhawale | 13 | 33 | 524 |
| Rajiv Baijal | 13 | 36 | 1075 |
| Gautam Allahbadia | 13 | 145 | 745 |